NVCR CIK: 1645113

NovoCure Ltd

  • Switzerland
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
420
FY22:
423
FY23:
381
FY24:
468
FY25:
488
(positive)
Change from FY21 to FY25
millions USD
FY21:
−44.3
FY22:
−89.5
FY23:
−233
FY24:
−170
FY25:
−154
(positive)
Change from FY21 to FY25
millions USD
FY21:
−34.4
FY22:
−64.4
FY23:
−177
FY24:
−109
FY25:
−100
(positive)
Change from FY21 to FY25
millions USD
FY21:
−52.1
FY22:
−81.8
FY23:
−192
FY24:
−131
FY25:
−136
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.4
FY22:
−92.5
FY23:
−207
FY24:
−169
FY25:
−136

All amounts in millions USD Data sources:SEC EDGARTwelve Data